CHINA PHARMA HOLDINGS, INC. Current Federal Tax Expense (Benefit)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Current Federal Tax Expense (Benefit) of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2017-05-11
- CHINA PHARMA HOLDINGS, INC. current federal tax expense (benefit) for the quarter ending 2017-03-31 was $0.00.
| Period end | Current Federal Tax Expense (Benefit) 3 month |
|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |